Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

2010 ◽  
Vol 32 (5) ◽  
pp. 615-623 ◽  
Author(s):  
Ross L Norris ◽  
Jennifer H Martin ◽  
Erin Thompson ◽  
John E Ray ◽  
Robert O Fullinfaw ◽  
...  
Keyword(s):  
Professional Development ◽  
New Zealand ◽  
Therapeutic Drug Monitoring ◽  
Practice Guidelines ◽  
Drug Monitoring ◽  
Best Practice ◽  
Current Status ◽  
Therapeutic Drug ◽  
Best Practice Guidelines

Therapeutic drug monitoring in HIV infection: current status and future directions

AIDS ◽  
2002 ◽  
Vol 16 ◽  
pp. S5-S37 ◽  
Author(s):  
David Back ◽  
Giorgio Gatti ◽  
Courtney Fletcher ◽  
Rodolphe Garaffo ◽  
Richard Haubrich ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Hiv Infection ◽  
Drug Monitoring ◽  
Current Status ◽  
Therapeutic Drug ◽  
Future Directions

scholarly journals Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

2016 ◽  
Vol 12 (5) ◽  
pp. 509-521 ◽  
Author(s):  
Marlanka A. Zuur ◽  
Mathieu S. Bolhuis ◽  
Richard Anthony ◽  
Alice den Hertog ◽  
Tridia van der Laan ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Current Status ◽  
Therapeutic Drug

scholarly journals Role of therapeutic drug monitoring of azathioprine and thiopurine methyltransferase enzyme status in patients with inflammatory bowel disease: Indian scenario

2020 ◽  
Vol 9 (10) ◽  
pp. 1618
Author(s):  
Maninder Singh ◽  
Sandeep Kaushal ◽  
Kanchan Gupta ◽  
Ajit Sood
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Anal Verge ◽  
Current Status ◽  
Therapeutic Drug ◽  
Chron's Disease ◽  
Inflammatory Bowel

Inflammatory bowel disease is mainly caused by dysragulated immune system. Inflammatory bowel disease incidences are rising in Asian countries with difficulty in their diagnosis and managements. There is rising the incidences and prevalence rate in India. Inflammatory bowel disease has two major subtypes Ulcerative colitis and chron’s disease. In ulcerative colitis inflammation occurs in lower part of large intestine that extend from anal verge to proximal colon while in case of chron’s disease there is transmural inflammation of gastrointestinal tract. This review is to provide comprehensive review focused on the current status of therapeutic drug monitoring of azathioprine metabolites in patients of inflammatory bowel disease.

Sign in / Sign up

Export Citation Format

Share Document